Lifestance Health Group Inc (LFST)

Lifestance Health Group experienced significant insider trading activity recently, characterized by substantial divestments from major shareholders and directors. Following a positive earnings report, the stock price surged 46.9% over ninety days. These transactions reflect large-scale selling pressure from institutional entities and key leadership, despite the company trading near its fifty-two-week peak.
Ticker: LFST Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Lifestance Health Group Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Proposed sale 11 Aug 2026
Value US$2,988,473.52 | Price 181.08 | Shares 98,325
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-11 2026-08-11 PrS Proposed sale

Director

Non-Executive Director
98,325
181.08
US$2,988,474
98,325 181.08 US$2,988,474
2026-08-10 2026-08-10 PrS Proposed sale

Stockholder

Large shareholder
82,329
147.37
US$77,691
82,329 147.37 US$77,691
2026-08-10 2026-08-10 PrS Proposed sale

Owner

58,355
174.88
US$3,420,455
58,355 174.88 US$3,420,455
2026-08-10 2026-08-10 PrS Proposed sale

Owner

1,000
10.62
US$100,000
1,000 10.62 US$100,000
2026-08-10 2026-08-10 PrS Proposed sale

Owner

1,000
10.62
US$100,000
1,000 10.62 US$100,000
2026-08-10 2026-08-10 PrS Proposed sale

Owner

1,000
10.62
US$100,000
1,000 10.62 US$100,000
2026-08-10 2026-08-10 PrS Proposed sale

Owner

1,000
10.62
US$100,000
1,000 10.62 US$100,000
2026-08-10 2026-08-10 PrS Proposed sale

Officer

Officer
1,000
10.85
US$100,000
1,000 10.85 US$100,000
2026-08-10 2026-08-10 PrS Proposed sale

Officer

Officer
1,000
10.85
US$100,000
1,000 10.85 US$100,000
2026-06-30 2026-06-26 S Sale Non-Executive Director
447,169 -40.5%
10.13
US$4,529,822
447,169 -40.5% 10.13 US$4,529,822
2026-06-30 2026-06-26 S Sale Non-Executive Director
447,168 -45.3%
10.13
US$4,529,812
447,168 -45.3% 10.13 US$4,529,812
2026-06-26 2026-06-26 PrS Proposed sale

Director

Non-Executive Director
894,337
10.13
US$9,060,618
894,337 10.13 US$9,060,618
2026-05-14 2026-05-12 S Sale Non-Executive Director
243,362 -21.9%
8.02
US$1,951,763
243,362 -21.9% 8.02 US$1,951,763
2026-05-14 2026-05-12 S Sale Non-Executive Director
287,517 -20.7%
8.02
US$2,305,886
287,517 -20.7% 8.02 US$2,305,886
2026-05-14 2026-05-12 S Sale Non-Executive Director
287,517 -22.6%
8.02
US$2,305,886
287,517 -22.6% 8.02 US$2,305,886
2026-05-14 2026-05-12 S Sale Non-Executive Director
5,899,661 -20.2%
8.02
US$47,315,281
5,899,661 -20.2% 8.02 US$47,315,281
2026-05-14 2026-05-12 S Sale Large shareholder
28,281,943 -20.2%
8.02
US$226,821,183
28,281,943 -20.2% 8.02 US$226,821,183
2026-05-11 2026-05-07 S Sale Non-Executive Director
37,500 -2.7%
8.55
US$320,625
37,500 -2.7% 8.55 US$320,625
2026-05-11 2026-05-07 S Sale Non-Executive Director
37,500 -2.9%
8.55
US$320,625
37,500 -2.9% 8.55 US$320,625
2026-05-07 2026-05-07 PrS Proposed sale

Director

Non-Executive Director
75,000
8.55
US$641,580
75,000 8.55 US$641,580
2026-04-27 2026-04-24 S Sale Non-Executive Director
31,074 -2.2%
7.05
US$219,072
31,074 -2.2% 7.05 US$219,072
2026-04-27 2026-04-24 S Sale Non-Executive Director
31,073 -2.4%
7.05
US$219,065
31,073 -2.4% 7.05 US$219,065
2026-04-24 2026-04-24 PrS Proposed sale

Director

Non-Executive Director
62,147
7.05
US$438,074
62,147 7.05 US$438,074
2026-04-27 2026-04-23 S Sale Non-Executive Director
3,876 -0.3%
7.00
US$27,132
3,876 -0.3% 7.00 US$27,132
2026-04-27 2026-04-23 S Sale Non-Executive Director
3,876 -0.3%
7.00
US$27,132
3,876 -0.3% 7.00 US$27,132
2026-04-23 2026-04-23 PrS Proposed sale

Director

Non-Executive Director
7,752
7.00
US$54,267
7,752 7.00 US$54,267
2026-04-23 2026-04-21 S Sale Non-Executive Director
2,550 -0.2%
7.01
US$17,876
2,550 -0.2% 7.01 US$17,876
2026-04-23 2026-04-21 S Sale Non-Executive Director
2,551 -0.2%
7.01
US$17,883
2,551 -0.2% 7.01 US$17,883
2026-04-21 2026-04-21 PrS Proposed sale

Director

Non-Executive Director
5,101
7.01
US$35,749
5,101 7.01 US$35,749
2026-03-04 2026-03-02 S Sale Large shareholder
20,685,061 -12.9%
7.01
US$145,002,278
20,685,061 -12.9% 7.01 US$145,002,278
2026-03-04 2026-03-02 S Sale Non-Executive Director
4,314,939 -12.9%
7.01
US$30,247,722
4,314,939 -12.9% 7.01 US$30,247,722
2025-12-23 2025-12-22 S Sale Non-Executive Director
851 -0.1%
7.04
US$5,991
851 -0.1% 7.04 US$5,991
2025-12-23 2025-12-22 S Sale Non-Executive Director
850 -0.1%
7.04
US$5,984
850 -0.1% 7.04 US$5,984
2025-12-22 2025-12-22 PrS Proposed sale

Director

Non-Executive Director
1,701
7.04
US$11,975
1,701 7.04 US$11,975
2025-12-23 2025-12-19 S Sale Non-Executive Director
59,971 -4.0%
7.04
US$422,196
59,971 -4.0% 7.04 US$422,196
2025-12-23 2025-12-19 S Sale Non-Executive Director
59,971 -4.3%
7.04
US$422,196
59,971 -4.3% 7.04 US$422,196
2025-12-19 2025-12-19 PrS Proposed sale

Director

Non-Executive Director
119,942
7.04
US$844,056
119,942 7.04 US$844,056
2025-12-19 2025-12-18 S Sale Non-Executive Director
3,221 -0.2%
7.00
US$22,547
3,221 -0.2% 7.00 US$22,547
2025-12-19 2025-12-18 S Sale Non-Executive Director
3,221 -0.2%
7.00
US$22,547
3,221 -0.2% 7.00 US$22,547
2025-12-18 2025-12-18 PrS Proposed sale

Director

Non-Executive Director
6,442
7.00
US$45,113
6,442 7.00 US$45,113
2025-12-19 2025-12-17 S Sale

Chief People Officer

Officer
50,000 -13.7%
6.90
US$345,000
50,000 -13.7% 6.90 US$345,000
2025-12-17 2025-12-17 PrS Proposed sale

Officer

Officer
50,000
6.90
US$344,843
50,000 6.90 US$344,843
2025-12-16 2025-12-15 S Sale Non-Executive Director
6,185 -0.4%
7.00
US$43,295
6,185 -0.4% 7.00 US$43,295
2025-12-16 2025-12-15 S Sale Non-Executive Director
6,186 -0.4%
7.00
US$43,302
6,186 -0.4% 7.00 US$43,302
2025-12-15 2025-12-15 PrS Proposed sale

Director

Non-Executive Director
12,371
7.00
US$86,622
12,371 7.00 US$86,622
2025-12-16 2025-12-12 S Sale Non-Executive Director
39,815 -2.6%
7.01
US$279,103
39,815 -2.6% 7.01 US$279,103
2025-12-16 2025-12-12 S Sale Non-Executive Director
39,815 -2.8%
7.01
US$279,103
39,815 -2.8% 7.01 US$279,103
2025-12-12 2025-12-12 PrS Proposed sale

Director

Non-Executive Director
79,630
7.01
US$558,222
79,630 7.01 US$558,222
2025-11-25 2025-11-21 S Sale

See Remarks

Officer
57,240 -18.0%
6.43
US$368,053
57,240 -18.0% 6.43 US$368,053
2025-11-21 2025-11-21 PrS Proposed sale

Officer

Officer
57,240
6.43
US$368,143
57,240 6.43 US$368,143
2025-08-20 2025-08-18 S Sale

Member of 10% Group

3,592,357 -20.1%
5.07
US$18,213,250
3,592,357 -20.1% 5.07 US$18,213,250
2025-08-20 2025-08-18 S Sale Non-Executive Director Large shareholder
8,407,643 -20.1%
5.07
US$42,626,750
8,407,643 -20.1% 5.07 US$42,626,750
2025-08-20 2025-08-18 S Sale Large shareholder
8,407,643 -20.1%
5.07
US$42,626,750
8,407,643 -20.1% 5.07 US$42,626,750
2025-08-18 2025-08-18 PrS Proposed sale

Shareholder

894,098
5.41
US$4,837,070
894,098 5.41 US$4,837,070
2025-08-18 2025-08-18 PrS Proposed sale

Shareholder

2,471,741
5.41
US$13,372,119
2,471,741 5.41 US$13,372,119
2025-08-18 2025-08-18 PrS Proposed sale

Shareholder

226,518
5.41
US$1,225,462
226,518 5.41 US$1,225,462
2025-08-18 2025-08-18 PrS Proposed sale

Owner

3,214,648
5.41
US$17,391,246
3,214,648 5.41 US$17,391,246
2025-08-18 2025-08-18 PrS Proposed sale

Owner

5,148,494
5.41
US$27,853,353
5,148,494 5.41 US$27,853,353
2025-08-18 2025-08-18 PrS Proposed sale

Owner

4,804
5.41
US$25,990
4,804 5.41 US$25,990
2025-08-18 2025-08-18 PrS Proposed sale

Owner

35,938
5.41
US$194,425
35,938 5.41 US$194,425
2025-08-18 2025-08-18 PrS Proposed sale

Owner

3,759
5.41
US$20,336
3,759 5.41 US$20,336
2025-08-12 2025-08-11 B Purchase Non-Executive Director
18,660 +0.5%
4.54
US$84,716
18,660 +0.5% 4.54 US$84,716
2025-08-12 2025-08-11 B Purchase Non-Executive Director
1,340 +0.0%
4.35
US$5,829
1,340 +0.0% 4.35 US$5,829
2025-08-12 2025-08-08 B Purchase Non-Executive Director
46,511 +inf%
4.30
US$199,997
46,511 +inf% 4.30 US$199,997
2025-08-12 2025-08-08 B Purchase Non-Executive Director
1,800 +0.1%
4.31
US$7,758
1,800 +0.1% 4.31 US$7,758
2025-08-12 2025-08-08 B Purchase Non-Executive Director
45,870 +1.4%
4.36
US$199,993
45,870 +1.4% 4.36 US$199,993
2025-06-18 2025-06-16 S Sale

Chief Medical Officer

Officer
9,519 -8.4%
5.17
US$49,213
9,519 -8.4% 5.17 US$49,213
2025-06-16 2025-06-16 PrS Proposed sale

Officer

Officer
9,519
5.17
US$49,213
9,519 5.17 US$49,213
2025-06-09 2025-06-05 S Sale

Chief Medical Officer

Officer
16,000 -12.4%
5.94
US$95,040
16,000 -12.4% 5.94 US$95,040
2025-06-05 2025-06-05 PrS Proposed sale

Officer

Officer
16,000
5.94
US$94,961
16,000 5.94 US$94,961
2025-04-10 2025-04-09 S Sale Non-Executive Director
2,450 -0.2%
7.01
US$17,174
2,450 -0.2% 7.01 US$17,174
2025-04-10 2025-04-09 S Sale Non-Executive Director
2,450 -0.2%
7.01
US$17,174
2,450 -0.2% 7.01 US$17,174
2025-04-09 2025-04-09 PrS Proposed sale

Director

Non-Executive Director
4,900
7.01
US$34,338
4,900 7.01 US$34,338
2025-04-10 2025-04-08 S Sale Non-Executive Director
7 -0.0%
7.00
US$49
7 -0.0% 7.00 US$49
2025-04-10 2025-04-08 S Sale Non-Executive Director
7 -0.0%
7.00
US$49
7 -0.0% 7.00 US$49